image class="left" url="http://media5.picsearch.com/is?IffHNIoouNIDhdT2OeagqSYhxjn0b_lw0YxnQjzF2t0&height=248"Our attorneys have filed a mass tort lawsuit on behalf of individuals who took the blood thinner Xarelto (rivaroxaban) and suffered critical bleeding events. Pharmaceutical businesses, which includes the makers of extra resources Xarelto, have a duty to ensure that their drugs are reasonably safe for use - and failure to do so could be grounds for compensation. Our lawyers are working challenging to acquire these hurt by the drug the compensation they're entitled to.













While bleeding is a widespread complication related with anticoagulants, it has been alleged that Xarelto is far more dangerous than conventional blood thinners simply because no antidote exists to reverse its blood-thinning effects. This means that, inside the occasion of an emergency, patients may be at threat for irreversible bleeding problems, including life-threatening internal and gastrointestinal hemorrhaging.













In case you or even a loved one particular suffered a serious bleeding event after taking Xarelto, you might have legal recourse. For much more data, make contact with us these days to possess your case reviewed, free of charge of charge.






Compensation Possibilities













xarelto-compensation-photoThe plaintiffs in these lawsuits are in search of compensation from Bayer and Janssen for past and future healthcare bills, lost wages, discomfort and suffering and, in cases of death, funeral costs. In addition, they're seeking punitive damages, that are usually awarded to punish the defendant and deter other businesses from acting similarly.






Why Are Lawsuits Becoming Filed?













Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is hazardous and defective. The plaintiffs claim that, unlike conventional anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Simply because of this, the lawsuits claim, doctors have no effective implies of stopping Xarelto users from bleeding in the event of an emergency. Plaintiffs inside the lawsuits allege severe and fatal injuries, such as cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.













In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:













The manufacturers of Xarelto marketed the drug as a superior within the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.






The makers of the drug continue to market Xarelto as a safe anticoagulant option.






Doctors and medical staff were not properly made aware of methods to stabilize and treat a Xarelto user in the occasion of a bleeding complication.






Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding event.






Xarelto is linked to serious bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing dangerous clotting.













Visit this page for more info on the alleged health risks of Xarelto.






Multidistrict Litigation Trial Dates Set













The attorneys inside the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.
There are no comments on this page.
Valid XHTML :: Valid CSS: :: Powered by WikkaWiki